Most have not been adequately evaluated in long-term studies and virtually none in randomized clinical trials. In addition, the panel strongly encouraged professional education to insure proper and safe practice in the treatment of TMD, particularly with regard to medications, surgery, and understanding the psychological and social aspects of these TMD problems. T he panel made their recommendations at the conclusion of the 3-day NIH Technology Assessment Conference on Management of Temporomandibular Disorders. The conference was convened by the National Institute of Dental Research and the NIH Office of Medical Applications of Research. T he conference was cosponsored by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the National Institute of Neurological Disorders and Stroke, the National Institute of Nursing Research, and the NIH Office of Research on Women's Health.
C lick here to see the full text of the statement.